These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22171127)

  • 1. Vascular endothelial growth factor 165b expression in stromal cells and colorectal cancer.
    Tayama M; Furuhata T; Inafuku Y; Okita K; Nishidate T; Mizuguchi T; Kimura Y; Hirata K
    World J Gastroenterol; 2011 Nov; 17(44):4867-74. PubMed ID: 22171127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF
    Boudria A; Abou Faycal C; Jia T; Gout S; Keramidas M; Didier C; Lemaître N; Manet S; Coll JL; Toffart AC; Moro-Sibilot D; Albiges-Rizo C; Josserand V; Faurobert E; Brambilla C; Brambilla E; Gazzeri S; Eymin B
    Oncogene; 2019 Feb; 38(7):1050-1066. PubMed ID: 30194450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological implications of vascular endothelial growth factor 165b expression in oral squamous cell carcinoma stroma.
    Nagasaki M; Kondo S; Mukudai Y; Kamatani T; Akizuki A; Yaso A; Shimane T; Shirota T
    Oncol Rep; 2016 Jul; 36(1):573-81. PubMed ID: 27221145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p73 Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis.
    Díaz R; Peña C; Silva J; Lorenzo Y; García V; García JM; Sánchez A; Espinosa P; Yuste R; Bonilla F; Domínguez G
    Int J Cancer; 2008 Sep; 123(5):1060-7. PubMed ID: 18546269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel molecular marker of prognosis in colorectal cancer: Vasohibin-1.
    Yan Y; Shen Z; Ye Y; Jiang K; Zhang H; Shen C; Mustonen H; Puolakkainen P; Wang S
    Med Oncol; 2014 Feb; 31(2):816. PubMed ID: 24366689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.
    Abajo A; Bitarte N; Zarate R; Boni V; Lopez I; Gonzalez-Huarriz M; Rodriguez J; Bandres E; Garcia-Foncillas J
    World J Gastroenterol; 2012 Feb; 18(7):637-45. PubMed ID: 22363134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How VEGF-A and its splice variants affect breast cancer development - clinical implications.
    Al Kawas H; Saaid I; Jank P; Westhoff CC; Denkert C; Pross T; Weiler KBS; Karsten MM
    Cell Oncol (Dordr); 2022 Apr; 45(2):227-239. PubMed ID: 35303290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome.
    Barresi V; Di Gregorio C; Regiani-Bonetti L; Ponz-De Leon M; Barresi G; Vitarelli E
    Virchows Arch; 2010 Jul; 457(1):11-9. PubMed ID: 20532559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New molecular staging with G-factors (VEGF-C and Reg IV) by supplementing TNM classification in colorectal cancers.
    Sawada T; Yashiro M; Sentani K; Oue N; Yasui W; Miyazaki K; Kai K; Fujita H; Nakamura K; Maeda K; Kakeji Y; Natsugoe S; Shirabe K; Nomura S; Shimada Y; Tomita N; Hirakawa K; Maehara Y
    Oncol Rep; 2013 Dec; 30(6):2609-16. PubMed ID: 24101199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
    Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
    Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of integrin beta3 mRNA and vascular endothelial growth factor protein expression profiles with the clinicopathological features and prognosis of gastric carcinoma.
    Li SG; Ye ZY; Zhao ZS; Tao HQ; Wang YY; Niu CY
    World J Gastroenterol; 2008 Jan; 14(3):421-7. PubMed ID: 18200665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma.
    Zheng S; Han MY; Xiao ZX; Peng JP; Dong Q
    World J Gastroenterol; 2003 Jun; 9(6):1227-30. PubMed ID: 12800229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer.
    Minagawa N; Nakayama Y; Hirata K; Onitsuka K; Inoue Y; Nagata N; Itoh H
    Anticancer Res; 2002; 22(5):2957-63. PubMed ID: 12530025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor and its receptor KDR (kinase domain-containing receptor)/Flk-1 (fetal liver kinase-1) as prognostic factors in human colorectal cancer.
    Harada Y; Ogata Y; Shirouzu K
    Int J Clin Oncol; 2001 Oct; 6(5):221-8. PubMed ID: 11723743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma.
    Kuwai T; Kitadai Y; Tanaka S; Onogawa S; Matsutani N; Kaio E; Ito M; Chayama K
    Int J Cancer; 2003 Jun; 105(2):176-81. PubMed ID: 12673675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.